Makes joint injections for osteoarthritis in dogs and horses.
Jun 2026Revenue $1.18M/yrExpenses $10.0M/yr
No trend
Figures by year
When will PetVivo Holdings be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.18M and expenses $10.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $1.14M | $10.2M | −$9.06M |
| Mar 2025 | $1.13M | $9.19M | −$8.06M |
| Mar 2024 | $969K | $11.6M | −$10.6M |
| Mar 2023 | $917K | $9.65M | −$8.73M |
| Mar 2022 | $116K | $5.17M | −$5.06M |
| Mar 2021 | $12.6K | $1.97M | −$1.96M |
| Mar 2020 | $3.59K | $2.02M | −$2.02M |
| Mar 2018 | $1.51K | $2.29M | −$2.29M |
| Mar 2017 | $7.12K | $16.4M | −$16.4M |
| Mar 2016 | $75.0K | $3.33M | −$3.25M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.